Introduction: Attention deficit hyperactivity disorder (ADHD) is a neuropsychiatric pathology that has an important prevalence among young people and is difficult to diagnose. It is usually treated with methylphenidate, a psychostimulant with a mechanism of action similar to that of cocaine. Previous studies show that repeated use of psychostimulants during childhood or adolescence may sensitize subjects, making them more prone to later abuse of psychostimulant drugs such as cocaine and methamphetamine. Objective: To review experimental studies in non-human models (rodents and monkeys) treated with methylphenidate during infancy or adolescence and tested for reinforcing effects on psychostimulant drugs in adulthood. Method: Systematic collection of data was performed on four databases (Web of Knowledge, PsycARTICLE, PubMed and SciE-LO). The initial search identified 202 articles published from 2009 to 2014, which were screened for eligibility. Seven articles met the inclusion criteria and were reviewed in this study.
Introduction
Stimulant drugs have been used to treat attention deficit hyperactivity disorder (ADHD) for more than 70 years. This disorder is usually diagnosed in children and teenagers and may persist through adulthood. 1 Relevant concerns have been raised in recent decades regarding the impact of chronic use of psychostimulants such as methylphenidate (MPH) during brain development.
One pertinent point raised is the hypothesis that use of MPH during childhood and adolescence may sensitize the developing brain, eliciting susceptibility to drug abuse (especially to psychostimulants) in adulthood. 2 Considering the widespread use of this drug, studies that aim to investigate its potential impact on the development of the brain are warranted, especially when they concern potential adverse consequences such as drug addiction.
Attention deficit hyperactivity disorder is a neuropsychiatric pathology with an important prevalence among young people and its rate of diagnosis has increased by 41% over the last 10 years, with a significant increase among male adolescents aged 14 to 17.
3 Diagnosis of this disorder is based on persistent dysfunctional levels of attention, impulsivity and motor activity (hyperactivity). 4 To date there are no known biological markers or laboratory tests that can confirm its presence and so the disorder is mainly identified through observation of behavioral features. 4 According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5 ADHD is characterized by 18 symptoms, nine of which are related to inattention traits, six to hyperactivity traits and three to impulsivity traits. The cutoff for diagnosis is six traits, i.e. the number of symptoms above which the subject is diagnosed with ADHD is six inattention traits and/or six hyperactivity-impulsivity traits. The cutoff for adults is five traits.
The pathophysiology of ADHD is believed to be related to an abnormality within the catecholaminergic signaling system involving release of dopamine (DA) in areas such as the frontal lobe and those involving the limbic system. 6 One theory postulated to explain the etiology of ADHD is a fronto-striatal dopaminergic hypofunction.
Because the frontal lobe, mainly the prefrontal cortex, is responsible for attentional and regulatory processes (inhibitory control, impulsivity), and the nigrostriatal pathway is responsible for motor activities (hyperactivity), the clinical features of ADHD correlate to the areas involved. However, the neurobiology of this disorder is likely to involve more than dopaminergic hypofunction, since not all patients respond well to the standard medication, MPH, and not all psychostimulants appear to be effective for treatment. 6, 7 The pharmacological action of MPH is ascribed to blockage of dopamine (DA) and noradrenaline (NA) reuptake within the prefrontal cortex, thereby increasing the levels of both neurotransmitters in this region and enhancing the functions for which they are responsible (attention, inhibitory control and working memory). 1 Interestingly, cocaine also causes increased availability of DA, in particular in the dopaminergic mesolimbic pathway, which is known as the reward pathway in the brain. A large body of evidence suggests that this action within the reward circuitry underlies the addictive properties of cocaine. 6, [8] [9] [10] Thus, both ADHD patients and people addicted to cocaine are likely to have a common neuronal need for dopaminergic stimulation.
Nonetheless, the direction of this relationship in terms of whether MPH sensitizes the subject's brain for subsequent use of psychostimulants or constitutes a protective tool remains a mystery.
On one hand, some studies have assessed utilization of MPH as a pharmacological tool for treatment of cocaine 11, 12 and methamphetamine (MET) 13 vulnerability to the reinforcing effects of cocaine, as observed through increased cocaine self-administration.
Another study using a non-human primate model (Rhesus monkeys) was designed to compare the reinforcing properties of Atomoxetine, a non-stimulant medication for ADHD, with the effects of two other drugs, MPH and desipramine. In order to achieve this, the animals were initially sensitized with cocaine and afterwards were
given the opportunity to self-administer atomoxetine, desipramine or MPH. The results indicated that MPH, similarly to cocaine and conversely to Atomoxetine and Desipramine, functioned as a positive reinforcer. 29 These data support previous reports using rodents as models. 28 On the other hand, a more recent publication demonstrated that repeated treatment with intragastric MPH did not induce behavioral sensitization in adolescent rats. Additionally, cross-sensitization was also not observed when the animals underwent early treatment with MPH and were later challenged with nicotine during adolescence or adulthood. In the conditioned place preference (CPP) paradigm, animals are administered a drug prior to being placed in one environment/context. In another session they are administered with a neutral substance (a vehicle injection) before being placed in an alternative environment.
Materials and methods
Following several pairing sessions, the animals are allowed to move freely between the two environments, while in a drug-free state, and the amount of time spent in the drug-associated context is taken as an index of preference for the drug. [17] [18] [19] Another recurrent behavioral paradigm is used to assess aversive properties of drugs.
The conditioned taste aversion (CTA) task evaluates animals' tendency to reduce consumption of a usually preferred substance (e.g., sucrose, saccharin, water).
After several pairings of this substance with a specific drug, a reliable reduction in fluid intake is produced, thus conveying a learned association between the aversive effects of the drug and the taste of the substance.
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The self-administration model has been successfully used to measure psychostimulant reinforcement in non-human animal models. [21] [22] [23] In this model, animals are trained to perform an action in order to receive an infusion of a drug. In this kind of experiment, various different manipulations can be performed to examine their effects on self-administration. One useful feature of the self-administration model is its capacity to mimic real-life drug-taking in humans. 24 Finally, one further recurrent approach is an assessment of locomotor sensitization/crosssensitization, based on a phenomenon by which locomotor activity is enhanced following a drug challenge using a dose to which the animal has repeatedly been exposed previously. In cross-sensitization, animals repeatedly treated with one stimulant display greater locomotor activity when later exposed to another stimulant. 25 Locomotor sensitization is considered a behavioral model of drug induced neuronal plasticity, 26 being paralleled by neuroadaptations underlain by changes in molecular signaling cascades. 27 However, even using this kind of experimental evaluation, studies of MPH with humans and with nonhuman animal models have reported complex and variable results.
For instance, a study published by Brandon et al. 28 using adolescent male Sprague-Dawley (SD) rats demonstrated that MPH may have a sensitizing effect towards use of cocaine in adulthood. 13 Animals exhibited locomotor cross-sensitization when initially exposed to MPH and afterwards to cocaine. Pretreatment with MPH also increased self-administration of cocaine. 28 As such, were not available for online access.
At the end of this process, seven articles were selected for review ( Figure 1 ). The rate of agreement between the reviewers was 96.3%. In cases of discrepancies between the two reviewers' evaluations, a third researcher was requested to participate.
The articles reviewed were organized by author, publication year, sample size, animal model (including strain), MPH dose and route of administration, period of development during which the exposure to MPH was carried out, behavioral task and main results ( Table 1) . It is important to mention that the periods of development that were included in this review were from the beginning of weaning to late adolescence. Weaning is a transition between two modes of feeding, and is a progressive and developmental process unique to mammalian young.
Rats mature rapidly during infancy and become sexually mature at about 6 weeks of age. Year of publication (78) Language (3) Objtective of study (31) Independent variable (4)
Dependent variable (3)
Study design (1) Accessibility of article (1)
Total number of articles identified (n = 7)
to MPH during childhood/adolescence on subsequent use of psychostimulants. In contrast, two studies did observe such effects. Finally, the three remaining studies compared different methodological aspects such as animal strains, behavioral tasks or routes of drug administration. ♂ = male; ♀ = female; ↑ = increase; ↓ = decrease; CG = control group; CPP = conditioned place preference; CTA = conditioned taste aversion; DAT = dopamine transporter; EG = experimental group; Exp. = experiment; infus. = infusion; MPH = methylphenidate; NS = not significant; PFC = prefrontal cortex; SA = selfadministration; SHR = spontaneously hypertensive rat; WIS = Wistar rat; WKY = Wistar-Kyoto rat.
Results
In total, seven studies that met all of the inclusion criteria defined for this systematic review were included.
Two of these studies did not detect any effect from exposure Studies reporting no effect of early exposure to MPH on adult life The study published by Gill et al. 35 MPH use during development is growth suppression. 44, 45 Finally, the third objective was to evaluate vulnerability to the reinforcing effects of cocaine after pre-exposure to MPH, using the self-administration paradigm. Overall, no differences were found between groups in the availability of D2/D3 or DATs following exposure to MPH during late infancy. There were also no differences in morphometric measurements among animals that had been pre- Gill et al. 35 explain this inconsistency by highlighting the differences in the dose of cocaine initially delivered to the animals in the self-administration paradigm. In this study, Gill et al. 35 provided the animals with lower initial doses of cocaine, which were below reinforcing thresholds. It therefore seems logical that higher initial doses would result in a more pronounced difference between groups.
Studies reporting effects of early exposure to MPH on adult life
In contrast to the two studies described above, two other studies did find effects in adulthood following exposure to MPH during infancy/adolescence. 
Studies comparing the effects of different methodological aspects of early exposure to MPH on adult life
Finally, the three remaining studies organized in this last section share a common feature: they compared methodological aspects. In these studies different strains, behavioral paradigms and MPH administration protocols are compared.
In the first study, Peña et al. 37 For instance, increases in the rewarding value of cocaine were observed in rodents submitted to cocaine selfadministration, 3, 21 whereas animals (especially from the SHR strain) tested with the CPP task exhibit decreased rewarding effects. 37 To address this question, Crawford et al. 22 compared two different behavioral paradigms with the intention of revealing the effects of early exposure to MPH. This study also investigates sex differences using male and female rodents of the SD strain. The animals were exposed to MPH (0.2 mg/kg or 5 mg/kg, ip) during infancy and, after reaching adulthood, were submitted to cocaine self-administration (0.25 or 0.75 mg/kg, intravenous) and to the CPP paradigm with cocaine (0.1 or 20 mg/kg, ip).
Effects were only observed among male subjects that had been exposed to MPH and these effects were only observed in relation to cocaine self-administration. Females used in this study did not exhibit effects of exposure to MPH in any of the tasks. The authors observed that male rats exposed to MPH during infancy were more susceptible to the reinforcing properties of cocaine (accessed through self-administration) but were not sensitive to the cues related to cocaine, as observed through the CPP task.
The results reported by this study seem to suggest that observation of possible different reinforcing properties of cocaine following MPH administration may vary depending on the characteristics of the behavioral paradigm used. Regarding sex differences, it is relevant to observe that few studies include females in their assessments of early exposure to MPH. However, according to this study published by Crawford et al. 22 females seem to display different effects following such exposure when compared to male animals in the same period of the development. This difference may also be reflected in the subsequent predisposition to cocaine abuse. It is possible that hormonal particularities might underlie these differences, since estrogen has a neuroprotective role against some neurotoxic agents. 54, 55 Finally, Griggs et al. 23 also reported divergent results regarding exposure to MPH during infancy. In their work, male SD rodents were evaluated between the beginning and end of adolescence. The animals were exposed to MPH for a period of four weeks. Two drug administration protocols were used, continuous (1.6 or 3.2 mg/kg/ day via osmotic minipump) and intermittent (0.8 or 1.6 mg/kg, subcutaneously, twice daily). After drug administration, the rats were submitted to locomotor activity tests and the self-administration protocol. The effects of exposure to MPH were only observed in subjects that received the drug according to the intermittent administration protocol. Animals that received two daily doses of MPH, rather than receiving it continuously, were more sensitive to the reinforcing properties of cocaine.
The authors argue that the results convey enough evidence to state that sustained-release formulations are less likely to elicit the risk of subsequent substance abuse. This hypothesis reinforces the results obtained by Gill et al. 35 in their study with non-human primates. In general, the data compiled from the studies in this review suggest that exposure to MPH during infancy or adolescence may explain proneness to cocaine abuse, particularly in SHR rats, which constitute an animal model for ADHD. However, the diversity of strains used in the studies and the variety of tasks performed suggest a need for caution when evaluating the results.
Discussion
It is noteworthy that only one study assessed females and although ADHD does predominantly affect males, tests with females are nevertheless warranted if a better understanding of this disorder is to be achieved.
Furthermore, only one of the studies used a species other than rats (Rhesus monkeys), and although this species may offer useful information for a potential translational interpretation of the results, it is understood that the experiments dealt with non-ADHD Rhesus monkeys, which once more raises a crucial point, i.e.
that more suitable models are needed to provide a better understanding of this pathology. It is, however, well known that ADHD is a difficult to detect disorder, which may increase rates of false positive diagnoses, in turn implying that healthy subjects might be unnecessarily treated during their developmental periods. This possibility increases the relevance of studies using non-ADHD models, which also ought to be taken into account, since they provide further information on the effects of psychostimulants, especially MPH, on the typical developing brain.
Additionally, it is well known that studies with animals allow for neurobiological, neurochemical and morphological evaluation, and studies with rodents seem to exhibit positive results regarding the risk of psychostimulant consumption following treatment with MPH. Nevertheless, it is worth mentioning that a recently published meta-analysis compiling data from 15 studies with a total of 2,565 children found no effect of early treatment with MPH on later abuse of cocaine, marijuana, alcohol or nicotine. 16 The authors of that study concluded that use of MPH during childhood is not associated with either a decrease or an increase in proneness to later drug abuse. However, that study only assessed children, not adolescents, and this aspect may be relevant because the stage of development during which the subject is exposed to MPH appears to be a determining factor for prognosis of the disorder.
According to Humphreys, Eng & Lee, 16 
